{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:12:37Z","timestamp":1791353557197,"version":"4.3.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jtos.2014.12.006","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T07:30:36Z","timestamp":1428737436000},"page":"213-225","source":"Crossref","is-referenced-by-count":123,"title":["Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"13","author":[{"given":"Kelvin H.","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2014.12.006_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2014.12.006_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF00404705","article-title":"Prevalence of dry eye in Japanese eye centers","volume":"233","author":"Hikichi","year":"1995","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/00006324-199708000-00023","article-title":"A\u00a0patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada","volume":"74","author":"Doughty","year":"1997","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2014.12.006_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0420.1997.tb00774.x","article-title":"Keratoconjunctivitis sicca and primary Sjogren's syndrome in a Danish population aged 30-60 years","volume":"75","author":"Bjerrum","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jtos.2014.12.006_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9394(14)71688-5","article-title":"Prevalence of dry eye among the elderly","volume":"124","author":"Schein","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/bjo.68.5.321","article-title":"Diagnostic implications of tear protein profiles","volume":"68","author":"Mackie","year":"1984","journal-title":"Br J Ophthalmol"},{"issue":"Pt 4","key":"10.1016\/j.jtos.2014.12.006_bib7","first-page":"355","article-title":"The effect of ageing and disease on tear constituents","volume":"104","author":"Seal","year":"1985","journal-title":"Trans Ophthalmol Soc U K"},{"key":"10.1016\/j.jtos.2014.12.006_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jtos.2012.12.002","article-title":"Dry eye disease and microbial keratitis: is there a connection?","volume":"11","author":"Narayanan","year":"2013","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2014.12.006_bib9","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0161-6420(96)30415-6","article-title":"Endophthalmitis associated with microbial keratitis","volume":"103","author":"Scott","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2014.12.006_bib10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry eye disease: an immune-mediated ocular surface disorder","volume":"130","author":"Stevenson","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jtos.2013.07.003","article-title":"Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting","volume":"11","author":"Baudouin","year":"2013","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2014.12.006_bib12","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1167\/iovs.03-1145","article-title":"Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface","volume":"45","author":"Luo","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2014.12.006_bib13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.ICL.0000162759.79740.46","article-title":"Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface","volume":"31","author":"Luo","year":"2005","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2014.12.006_bib14","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.4049\/jimmunol.176.7.3950","article-title":"Desiccating stress induces T cell-mediated Sjogren's Syndrome-like lacrimal keratoconjunctivitis","volume":"176","author":"Niederkorn","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jtos.2014.12.006_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1167\/iovs.03-0903","article-title":"Differential regulation of membrane-associated mucins in the human ocular surface epithelium","volume":"45","author":"Hori","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2014.12.006_bib16","article-title":"Double-masked randomized controlled study evaluating topical 0.05% cyclosporine A in the treatment of meibomian gland dysfunction (posterior blepharitis)","volume":"44","author":"Perry","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2014.12.006_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/exer.1998.0520","article-title":"Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva","volume":"67","author":"Jumblatt","year":"1998","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2014.12.006_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0167-5699(93)90048-P","article-title":"FK506 and cyclosporin, molecular probes for studying intracellular signal transduction","volume":"14","author":"Liu","year":"1993","journal-title":"Immunol Today"},{"key":"10.1016\/j.jtos.2014.12.006_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0039-6257(86)90035-4","article-title":"Cyclosporine: immunology, pharmacology and therapeutic uses","volume":"31","author":"Nussenblatt","year":"1986","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00003226-199311000-00008","article-title":"Effect of topical cyclosporin A on conjunctival T cells in patients with secondary Sjogren's syndrome","volume":"12","author":"Power","year":"1993","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2014.12.006_bib21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0002-9394(14)70579-3","article-title":"An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis","volume":"121","author":"el-Asrar","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib22","unstructured":"Chapter 6.4.11: Search filters, in: Higgins JPT, Deeks JJ, Altman DG (eds). Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]: The Cochrane Collaboration, 2011, available from www.cochrane-handbook.org; 2011, Accessed April 21,\u00a02014."},{"key":"10.1016\/j.jtos.2014.12.006_bib23","first-page":"221","article-title":"Report of the National Eye Institute\/Industry workshop on Clinical Trials in Dry Eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"key":"10.1016\/j.jtos.2014.12.006_bib24","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1167\/iovs.06-1253","article-title":"Measurement of ocular surface irritation on a linear interval scale with the ocular comfort index","volume":"48","author":"Johnson","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2014.12.006_bib25","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1542-0124(12)70004-6","article-title":"Challenges and pitfalls in clinical trials of treatments for dry eye","volume":"1","author":"Foulks","year":"2003","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2014.12.006_bib27","unstructured":"Chapter 9.4.5.2: Meta-analysis of change scores, in: Higgins JPT, Deeks JJ, Altman DG (eds). Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]: The Cochrane Collaboration, 2011, available from www.cochrane-handbook.org; 2011, Accessed April 21,\u00a02014."},{"key":"10.1016\/j.jtos.2014.12.006_bib28","unstructured":"Chapter 8: Assessing risk of bias in included studies, in: Higgins JPT, Altman DG, Sterne JAC (eds). Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]: The Cochrane Collaboration, 2011, available from www.cochrane-handbook.org; 2011, Accessed April 21,\u00a02014."},{"key":"10.1016\/j.jtos.2014.12.006_bib29","unstructured":"Chapter 9: Analysing data and undertaking meta-analyses, in Deeks JJ, Higgins JPT, Altman DG (eds). Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]: The Cochrane Collaboration, 2011, available from www.cochrane-handbook.org; 2011, Accessed April 21,\u00a02014."},{"key":"10.1016\/j.jtos.2014.12.006_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/jop.2009.0145","article-title":"A\u00a0comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in chinese patients with moderate to severe dry eye disease: An eight-week, multicenter, randomized, double-blind, parallel-group trial","volume":"26","author":"Chen","year":"2010","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.jtos.2014.12.006_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1442-9071.2009.02090.x","article-title":"Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye","volume":"37","author":"Guzey","year":"2009","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.ico.0000176611.88579.0a","article-title":"Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction","volume":"25","author":"Perry","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2014.12.006_bib33","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/ICO.0b013e31823cc098","article-title":"A\u00a0randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction","volume":"31","author":"Prabhasawat","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2014.12.006_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/jop.2009.0091","article-title":"Topical cyclosporine 0.05% for the prevention of dry eye disease progression","volume":"26","author":"Rao","year":"2010","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.jtos.2014.12.006_bib35","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jcrs.2005.10.034","article-title":"Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis","volume":"32","author":"Salib","year":"2006","journal-title":"J\u00a0Cataract Refract Surg"},{"key":"10.1016\/j.jtos.2014.12.006_bib36","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2014.12.006_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/ICL.0b013e3180676d44","article-title":"Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes","volume":"34","author":"Willen","year":"2008","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2014.12.006_bib38","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/eye.2009.246","article-title":"Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients","volume":"24","author":"Altiparmak","year":"2010","journal-title":"Eye"},{"key":"10.1016\/j.jtos.2014.12.006_bib39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/ICL.0b013e31822563be","article-title":"Effects of topical cyclosporine A plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome","volume":"37","author":"Demiryay","year":"2011","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2014.12.006_bib40","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2147\/OPTH.S22647","article-title":"Efficacy of a new prescription-only medical food supplement in alleviating signs and symptoms of dry eye, with or without concomitant cyclosporine A","volume":"5","author":"Jackson","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajo.2008.08.015","article-title":"A\u00a0comparison of vitamin A and cyclosporine A 0.05% eye drops for treatment of dry eye syndrome","volume":"147","author":"Kim","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1076\/ceyr.22.1.8.6977","article-title":"The conjunctival epithelium in dry eye subtypes: effect of preserved and non-preserved topical treatments","volume":"22","author":"Albietz","year":"2001","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2014.12.006_bib43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/ICO.0b013e318158f6dc","article-title":"Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production","volume":"27","author":"Pflugfelder","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2014.12.006_bib44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1542-0124(12)70148-9","article-title":"Inflammation in dry eye","volume":"2","author":"Stern","year":"2004","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2014.12.006_bib45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.immuni.2007.03.014","article-title":"T\u00a0cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation","volume":"26","author":"Li","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jtos.2014.12.006_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3341\/kjo.2007.21.4.189","article-title":"Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye","volume":"21","author":"Moon","year":"2007","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib47","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00003226-199811000-00002","article-title":"The pathology of dry eye: the interaction between the ocular surface and lacrimal glands","volume":"17","author":"Stern","year":"1998","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2014.12.006_bib48","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1167\/iovs.02-1319","article-title":"Neurturin-deficient mice develop dry eye and keratoconjunctivitis sicca","volume":"44","author":"Song","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2014.12.006_bib49","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/bjo.82.6.666","article-title":"Frequent association of delayed tear clearance in ocular irritation","volume":"82","author":"Prabhasawat","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib50","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1475-1313.2003.00153.x","article-title":"The relation between tear film tests in patients with dry eye disease","volume":"23","author":"Nichols","year":"2003","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.jtos.2014.12.006_bib51","doi-asserted-by":"crossref","first-page":"e97921","DOI":"10.1371\/journal.pone.0097921","article-title":"Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease","volume":"9","author":"Alves","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jtos.2014.12.006_bib52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/aos.12012","article-title":"Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications","volume":"92","author":"Sullivan","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000315026","article-title":"Hyperosmolarity of the tear film in dry eye syndrome","volume":"45","author":"Messmer","year":"2010","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archophthalmol.2009.356","article-title":"Minimal clinically important difference for the ocular surface disease index","volume":"128","author":"Miller","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib55","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0161-6420(97)30125-0","article-title":"Relation between signs and symptoms of dry eye in the elderly. A population-based perspective","volume":"104","author":"Schein","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2014.12.006_bib56","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1167\/iovs.03-0270","article-title":"The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity","volume":"44","author":"Begley","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2014.12.006_bib57","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","article-title":"The lack of association between signs and symptoms in patients with dry eye disease","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2014.12.006_bib58","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/ICO.0b013e318225415a","article-title":"Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study","volume":"31","author":"Lemp","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2014.12.006_bib59","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ajo.2008.05.016","article-title":"Advances in understanding and managing dry eye disease","volume":"146","author":"Lemp","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jtos.2012.01.002","article-title":"The corneal pain system. Part I: the missing piece of the dry eye puzzle","volume":"10","author":"Rosenthal","year":"2012","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2014.12.006_bib61","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0008-4182(04)80071-1","article-title":"Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjogren's syndrome","volume":"39","author":"Adatia","year":"2004","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib62","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.ophtha.2005.05.013","article-title":"Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years","volume":"112","author":"Barber","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2014.12.006_bib63","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-servere dry eye disease: A dose-ranging, randomized trial","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2014.12.006_bib64","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.ophtha.2013.03.044","article-title":"Topical cyclosporine in the treatment of allergic conjunctivitis: a meta-analysis","volume":"120","author":"Wan","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2014.12.006_bib65","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0161-6420(86)33528-0","article-title":"The autoimmune nature of aqueous tear deficiency","volume":"93","author":"Pflugfelder","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2014.12.006_bib66","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bjo.68.9.674","article-title":"Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease","volume":"68","author":"Damato","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib67","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1371\/journal.pntd.0000264","article-title":"Role of secreted conjunctival mucosal cytokine and chemokine proteins in different stages of trachomatous disease","volume":"2","author":"Skwor","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jtos.2014.12.006_bib68","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0039-6257(96)80064-6","article-title":"Meibomian gland dysfunction","volume":"40","author":"Driver","year":"1996","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib69","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1542-0124(12)70299-9","article-title":"Predicted phenotypes of dry eye: proposed consequences of its natural history","volume":"7","author":"Bron","year":"2009","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2014.12.006_bib70","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clae.2005.12.004","article-title":"Dryness symptoms among an unselected clinical population with and without contact lens wear","volume":"29","author":"Chalmers","year":"2006","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.jtos.2014.12.006_bib71","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/ICO.0b013e31802dffc7","article-title":"Agreement of physician treatment practices with the international task force guidelines for diagnosis and treatment of dry eye disease","volume":"26","author":"Wilson","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2014.12.006_bib72","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1542-0124(12)70086-1","article-title":"Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2014.12.006_bib73","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1755-3768.1994.tb02792.x","article-title":"Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjogren's syndrome","volume":"72","author":"Gunduz","year":"1994","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.jtos.2014.12.006_bib74","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jtos.2014.12.006_bib75","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jama.289.4.454","article-title":"Scope and impact of financial conflicts of interest in biomedical research: a systematic review","volume":"289","author":"Bekelman","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jtos.2014.12.006_bib76","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/jamainternmed.2013.4190","article-title":"Industry sponsorship and research outcome: a Cochrane review","volume":"173","author":"Bero","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtos.2014.12.006_bib77","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/bjophthalmol-2013-304072","article-title":"Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease","volume":"98","author":"Sacchetti","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2014.12.006_bib78","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/ICO.0000000000000123","article-title":"Topical cyclosporine A in the treatment of dry eye: a systematic review and meta-analysis","volume":"33","author":"Zhou","year":"2014","journal-title":"Cornea"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012415000361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012415000361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T16:28:18Z","timestamp":1537720098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012415000361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1542012415000361"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2014.12.006","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}